Código QR

Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study

Abstract Introduction Data suggest that women and men differ in how they experience biological treatment. This post hoc analysis of the YU-MATTER study evaluated sex-related differences in patient satisfaction and perception when switching from adalimumab (reference or biosimilar) to CT-P17 (Yuflyma...

Descrición completa

Gardado en:
Principais autores: Laure Gossec, Guillaume Bouguen, Azeddine Dellal, Lucile Foulley, Caroline Habauzit, Salim Benkhalifa, Hubert Marotte
Formato: Artigo
Idioma:Inglês
Publicado: Adis, Springer Healthcare 2026-03-01
Series:Rheumatology and Therapy
Assuntos:
Adalimumab
Adverse events
Biosimilar
CT-P17
Injection site reactions
Patient-reported outcomes
Acceso en liña:https://doi.org/10.1007/s40744-026-00840-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares